Active Ingredient History
The MMR vaccine is a vaccine against measles, mumps, and rubella, abbreviated as MMR. The first dose is generally given to children around 9 months to 15 months of age, with a second dose at 15 months to 6 years of age, with at least four weeks between the doses. After two doses, 97% of people are protected against measles, 88% against mumps, and at least 97% against rubella. The vaccine is also recommended for those who do not have evidence of immunity, those with well-controlled HIV/AIDS, and within 72 hours of exposure to measles among those who are incompletely immunized. It is given by injection. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
BCG Vaccine (Phase 4)
Chickenpox (Phase 3)
Chikungunya Fever (Phase 2)
Diphtheria (Phase 3)
Haemophilus influenzae type b (Phase 3)
Healthy Volunteers (Phase 3)
Herpes Zoster Vaccine (Phase 3)
Immunity (Phase 4)
Measles (Phase 3)
Meningococcal Infections (Phase 3)
Mumps (Phase 3)
Neisseria meningitidis (Phase 3)
Papillomavirus Infections (Phase 3)
Pertussis Vaccine (Phase 3)
Poliomyelitis (Phase 3)
Rubella (Phase 3)
Tetanus (Phase 3)
Vaccines (Phase 4)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
